Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 10 of 23
Biose
Siparex Territoires
Sector
Biotech
InvestorSiparex
Entry
2021
Hold
5yr
bioXXmed AG
Deutsche Balaton Evergreen Holding (Balance Sheet)
Sector
Biotech
InvestorDeutsche Balaton Aktiengesellschaft
Entry
2024
Hold
2yr
bit.bio
BlueYard Capital Fund II
Sector
Biotech
InvestorBlueYard Capital
Entry
2019
Hold
7yr
Bitrobius Genetics
UK Innovation and Science Seed Fund
Sector
Biotech
InvestorFuture Planet Capital
Entry
2023
Hold
3yr
BiVictriX Therapeutics
Development Bank of Wales (Balance Sheet)
Sector
Biotech
InvestorDevelopment Bank of Wales
Entry
2016
Hold
10yr
Bota Bio
BASF Venture Capital Evergreen Fund
China
Sector
Biotech
InvestorBASF Venture Capital
Entry
2021
Hold
5yr
Botalys
ALIAD
Sector
Biotech
InvestorAliad Venture Capital
Entry
2022
Hold
4yr
Bright Biotech
FoodLabs Fund II
Sector
Biotech
InvestorFoodLabs
Entry
2022
Hold
4yr
Bright Peak Therapeutics
TVM Life Science Ventures
Sector
Biotech
InvestorTVM Capital Life Science
Entry
2020
Hold
6yr
Brink Therapeutics
Breega Seed fund
Sector
Biotech
InvestorBreega
Entry
2025
Hold
1yr
Broken String
DvH Ventures Fund IV (Digital Health Fund)
Sector
Biotech
InvestorDvH Ventures
Entry
2021
Hold
5yr
Capricorn Scientific GmbH
Hessen Kapital
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
Caris Life Sciences
Silver Lake Partners IV
Sector
Biotech
InvestorSilver Lake
Entry
–
CaSRevolution
Utopia SIS
Sector
Biotech
InvestorUtopia SIS
Entry
2023
Hold
3yr
Cebiotex
Inveready Biotech II
Sector
Biotech
InvestorInveready Asset Management
Entry
2016
Hold
10yr
Celea Therapeutics
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2026
Hold
0yr
CellCentric
UK Innovation and Science Seed Fund
Sector
Biotech
InvestorFuture Planet Capital
Entry
–
CellDrive
BeAble Innvierte KETs Fund
Sector
Biotech
InvestorBeAble Capital
Entry
2021
Hold
5yr
Cellino Biotech
Leaps by Bayer
Sector
Biotech
InvestorLeaps by Bayer
Entry
2022
Hold
4yr
Centauri Therapeutics
Boehringer Ingelheim Venture Fund
Sector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2022
Hold
4yr
Cephagenix
AFB Fund II
Sector
Biotech
InvestorAdBio Partners
Entry
2025
Hold
1yr
Cerevance
Dementia Discovery Fund
Sector
Biotech
InvestorSV Health Managers
Entry
2016
Hold
10yr
Cimico
Moira Capital Desarrollo
Sector
Biotech
InvestorMoira Capital Partners
Entry
2023
Hold
3yr
Cleara Biotech
Apollo Health Ventures Fund II
Sector
Biotech
InvestorApollo Health Ventures
Entry
2022
Hold
4yr
clock.bio
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2024
Hold
2yr
Cocoon Bioscience
Columbus Life Sciences Fund IV
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
Code Biotherapeutics
4BIO Ventures III
Sector
Biotech
Investor4Bio Partners
Entry
2022
Hold
4yr
Concert Bio
Nucleus Capital I
Sector
Biotech
InvestorNucleus Capital
Entry
2022
Hold
4yr
Concinnity Genetics
Old College Capital LP
Sector
Biotech
InvestorOld College Capital
Entry
2024
Hold
2yr
Confo Therapeutics
Wellington Partners Life Sciences
Sector
Biotech
InvestorWellington Partners
Entry
2019
Hold
7yr
Congruence Therapeutics
Angelini Ventures
Canada
Sector
Biotech
InvestorAngelini Ventures
Entry
2021
Hold
5yr
Connecta Therapeutics
Inveready Biotech III
Sector
Biotech
InvestorInveready Asset Management
Entry
2022
Hold
4yr
ConstructiveBio
Amadeus V Technology Fund
Sector
Biotech
InvestorAmadeus Capital Partners
Entry
2022
Hold
4yr
Corat Therapeutics GmbH
NBank Capital Beteiligungsfonds
Sector
Biotech
InvestorNBank Capital
Entry
2020
Hold
6yr
Core Biogenesis
Digital 3
Sector
Biotech
InvestorXAnge
Entry
2020
Hold
6yr
Corion Biotech
LIFTT
Sector
Biotech
InvestorLIFTT
Entry
2020
Hold
6yr
CoSyne Therapeutics
Backed Fund II
Sector
Biotech
InvestorBACKED VC
Entry
2022
Hold
4yr
Creasallis
BlueYard Capital Fund III
Sector
Biotech
InvestorBlueYard Capital
Entry
2023
Hold
3yr
Crucible Therapeutics
Northern Gritstone Evergreen
Sector
Biotech
InvestorNorthern Gritstone
Entry
2023
Hold
3yr
CrystalsFirst GmbH
Technologiefonds Hessen
Sector
Biotech
InvestorBMH Beteiligungsmanagement Hessen
Entry
2017
Hold
9yr
Cumulus Oncology
Scottish National Investment Bank (Balance Sheet)
Sector
Biotech
InvestorScottish National Investment Bank
Entry
2024
Hold
2yr
Curlim
AVA 1 (Aquiti Venture Amorcage)
Sector
Biotech
InvestorAquiti Gestion
Entry
2024
Hold
2yr
Curve Therapeutics
Columbus Life Sciences Fund IV
Sector
Biotech
InvestorColumbus Venture Partners
Entry
2024
Hold
2yr
cutanos
HTGF III
Sector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2021
Hold
5yr
CV6 Therapeutics
Co-Fund NI
Sector
Biotech
InvestorClarendon Fund Managers
Entry
2022
Hold
4yr
CV6 Therapeutics (NI) Ltd
QUBIS Ltd
Sector
Biotech
InvestorQubis
Entry
2019
Hold
7yr
Cyclarity Therapeutics
KIZOO Evergreen (Balance Sheet)
Sector
Biotech
InvestorKIZOO Technology Capital
Entry
2019
Hold
7yr
Cytoki Pharma
Ysios BioFund III
DK
Sector
Biotech
InvestorYsios Capital Partners
Entry
2021
Hold
5yr
Damona Pharmaceuticals
Angelini Ventures
Canada
Sector
Biotech
InvestorAngelini Ventures
Entry
2022
Hold
4yr
Dilafor
Rosetta Capital IV
Sector
Biotech
InvestorRosetta Capital
Entry
2013
Hold
13yr